FDA Investigator Devaughn Edwards

Devaughn Edwards has inspections in 15 countries as of 07 Sep 2023. Devaughn Edwards has collaborated with a combinined 6309 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
138
Last Inspection Date:
07 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, France, Italy, United Kingdom of Great Britain and Northern Ireland, India, Canada, Switzerland, Taiwan, Turkey, Germany, Japan, Ireland, Poland, Netherlands
Co-Investigator(s):
Aaron P Wozniak, Abdur Rashid, Adam R Cooke, Alan P Kurtzberg, Alberto A Viciedo, Amy Devlin, PhD, Amy H Ruble, Angela E Glenn, Arsen Karapetyan, Ashutosh Rao, PhD, Azza Talaat, Babatunde D Babalola, Barbara I Rogolsky, Barbara Jwilimczyk Macri, Barbara L Rogolsky, Barbara M Frazier, Betsy C Galliher, Billy M Battles, Bo Chi, PhD, Bonita S Chester, Bradley Dworak, PhD, Brandy D Brown, Brian D Nicholson, Brian J Ryan, Bridegan, Brown, Bryan A Galvez, Buford, Burnell M Henry, Calvin B Koerner, Candido Torres, Carl Lee, Carlos A Ortiz, Carlos M Gonzalez, Carolyn E Barney, Carr Sharpe, Caryn M Mcnab, CDR Donald Ertel, CDR Rochelle B Young, RPh, MSA, CDR Thomas R Berry, PPh, Chad E Schmear, Charisse K Green, Cherrie A Zachary, Cherry R Valerio, Cheryl A Clausen, Cheryl D Barton, Chestnut, Christian D Lynch (CDL), Christopher B May, Christopher Downey, PhD, Christopher S Keating, Claire M Minden, Claudette D Brooks, Constance Y Fears, Contractor Bridgers, Cordelia J Brammer, Courtney A Gilbert, Craig A Garmendia, Cynthia Jim, CSO, Dale A Nyberg, Daniel C Kearns, Daniel J Roberts, Daniel W Cline, Daphne Santiago, PhD, Daryl A Dewoskin, Debra I Love, Denise M Digiulio, Dennis Cantellops Paite, Derek C Price, Devaugh Edwards, Diane E Bruce, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Donald L Lech, Doretha M Tonkins, Douglas A Campbell, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Dr. Willie F Vann, PhD, Edecia A Richards, Edward Deberry, Eileen J Bannerman, Eliezar Ramos, Eric S Weilage, Erin C Hill, Esra Toussaint, Evaughn Edwards, Felix Maldonado, Gabriel R Mclemore, Gamal A Norton, Gary E Coleman, Jr, REHS, Gene D Arcy, German Rivera, Gideon N Esuzor, Gilbert T Salud, Hai Lent Phung, Hai Lien T Phung, Harshal J Desai, Hector A Carrero, Helen B Ricalde, Helen R Bester, Helen Verdel, Hristu B Chepa, Ibad U Khan, Igbinoba, Isabel Y Espinosa, Ivis Lnegron Torres, Ivy E Sweeney, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, James C Maclaughlin, James I Giefer, James P Lewis, Jr, James R Evans, Jared P Stevens, Jason F Chancey, Jawaid Hamid, Jee Chung, PhD, Jennifer D Hollstrom, Jennifer L Bridgewater, Jennifer Lalama, Jie He, Joanne T Gabay, Joe A Odom, Joey V Quitania, Jogy George, John D White, Johnson, Jonah S Ufferfilge, Jorge L Gonzalez, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose M Cayuela, Jose R Hernandez, Jose R Lopez, Joseph F Owens, Joseph Kutze, PhD, Joy Rkozlowski Klena, Julianne C Mccullough, Julie D Bringger, June P Page, Justin A Boyd, Kara D Dobbin, Karen Takahashi, Kassa Ayalew, MD, Kathleen B Swat, Kathleen D Culver, Kathryn E Ogger, Katrina B Mosley Sloan, Kemejumaka N Opara, Kenneth H Williams, Kent C Faul, Keri U Walker, Kevin A Gonzalez, Kevin D Kallander, Kewes, Kimberly Kroesen, Kirsten L Vadheim, PhD, Kula N Jha, Larry K Austin, Larry K Hampton, Latorie S Jones, Laura I Salazar, PhD, Laurel A Beer, Laurie Nelson, Lauryl A Smith, Lawrence Carter, III, Lei Zhang, PhD, Leo J Lagrotte, Leopold Kong, PhD, Lesley K Satterwhite, Leslie Arivera Rosado, PhD, Libia M Lugo, Lillie D Witcher, Liming Zhang, Linda F Murphy, Lois K Gross, LT Daveta L Bailey, LT Tamara J Henderson, Lucila B Nwatu, Luis A Dasta, Luis M Burgos Medero, Mancia R Walker, Marc A Alston, Marcia A Worley, Marianela Aponte Cruz, Marie F Morin, Marion Michaelis, Marisa E Stock, Mariza M Jafary, Marla A Cassidy, Mary Kaulee, Matthew B Casale, Matthew M Henciak, Megan A Haggerty, Melanie M Walker, Melissa J Garcia, Metitia G Sanders, Metitia M Gramby, Michael A Charles, Michael A Taylor, Michael E Maselli, Michael F Skelly, PhD, Michael R Goga, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Michelle D Haamid, Michelle Y Clark Stuart, Miguel A Martinez, Mihaly S Ligmond, Monica Cburgos Garcia, Morrell, Mra Davism, Mra Mcculloughj, Mra Munizn, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nancy G Schmidt, Nicholas A Violand, Nicole E Knowlton, Nicole M Bell, Niketa Patel, Noreen Muniz, Nydia E Colon, Omotunde O Osunsanmi, Pamela L Vega, Paraluman S Leonin, Parul M Patel, Patricia F Hudson, Patricia F Hughes, PhD, Patty P Kaewussdangkul, Paul A Bonneau, Paul E Stein, Paul L Bellamy, Paul Mouris, Paula A Trost, Paula J Bretz, Paula M Laplant, Pei I Chu, Penny H Mccarver, Perry H Gambrell, Philip F Istafanos, DMV, MS, Prabhu P Raju, Pratik S Upadhyay, DDC, Priscilla M Pastrana, R Edwadebey Deberry, Rachael L Cook, Rachael Lucinski, Radona R Boutte, Rajiv R Srivastava, Ralph A Erickson, Ralph H Vocque, Ramon E Martinez, Randy L Clarida, Rashard A Knight, Reba A Gates, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Rhonda Alexander, Richard H Penta, Richard Heath Coats, Richard Ledwidge (nmi), PhD, Ricki A Chase, Ricki Achase Off, Robert C Coleman, Robert D Tollefsen, Robert J Martin, Robert L Lewis, Jr, Robert W Jennings, Robin N Goins, Rose M Ashley, Rozelle G Smith, Ruth Moore, PhD, S Lori Brown, PhD MPH, Saied A Asbagh, Saleem A Akhtar, Samina S Khan, Samuel T Walker, Sangeeta M Khurana, PhD, Santos E Camara, Sarah L Holliday, Sayeeda Hdabe, Scott B Laufenberg, Scott T Ballard, Sean R Bryd, Seneca D Toms, Sereen Gmorgan Murray, Sharon K Thoma, PharmD, Shirley J Berryman, Sidney B Priesmeyer, Simon Williams, PhD, Sixto M Mercado Rios, Sonya M Edmonds, Srinivas R Chennamaneni, PhD, State Agency, Stephen D Brown, Steven A Gonzales, Steven D Kehoe, Steven Fong, MS, PhD, Susan M Jackson, Susan O Oladeji, Susan P Bruederle, Susan W Ting, Susanna E Ford, Analyst, Suzanne N Vallez, Tajah L Blackburn, Tamara M Casselman, Tamara M Felton, Tamika D Cathey, Tammara A Newberry, Tammara A Stephens, Tenzin Jangchup, Teresa C Thompson, Teresa I Navas, Terri L Dodds, Theresa Kirkham (NMI), Thomas J Arista, Thomas R Barry, Thomas R Withers, Thuy T Nguyen, LCDR, Timothy T Kapsala, Tomika L Bivens, Tonshina R Hall, Torrance J Slayton, Traci M Armand, Tracy R Ball, Tsedenia Woldehanna, Valerie J Grecek Trinh, Vanessa E Coulter, Vani Mathur Richards, Veronica Fuentes, MS, Vicky C Stoakes, Vincent M Williams, Viviana Matta, Vlada Matusovsky, Walden H Lee, Wayne D Mcgrath, Wayne E Seifert, Weedb, Wei Wang, PhD, Williams, Xiaoxiao Pan, PhD, Xiomara Copeland, Xuhong Li, Yonggang Wang, PhD, Yuan Chia Kuo, Yumi J Hiramine, Yun Wu, PhD, Zhao Wang, PhD, Zhenzhen Liu, PhD, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

Devaughn Edwards's Documents

Publish Date Document Type Title
October, 2003 FDA 483 Response Abbott Laboratories GmbH - Form 483R, 2003-10-17
July, 2004 FDA 483 Response Patheon Manufacturing Services LLC - Form 483R, 2004-08-16
March, 2001 EIR Allergan Pharmaceuticals Ireland - EIR, 2001-07-11
February, 2000 FDA 483 Bristol Myers Products Inc - Form 483, 2000-02-18
August, 2000 FDA 483 Response CIPLA LIMITED - Form 483R, 2000-09-07
November, 2002 EIR FUJIFILM Diosynth Biotechnologies U.S.A., Inc - EIR, 2002-11-13
June, 2000 EIR Alcami Carolinas Corporation - EIR, 2000-06-23
March, 2003 FDA 483 Purdue Pharmaceuticals L.P. - Form 483, 2003-03-13
October, 2003 EIR Abbott Laboratories GmbH - EIR, 2003-12-19
October, 2003 EIR Bayer AG - EIR, 2003-12-19
August, 2000 FDA 483 Response CIPLA LIMITED - Form 483R, 2000-09-11
September, 2003 EIR Hospira, Inc. - EIR, 2003-09-04
March, 2004 EIR Bayer AG - EIR, 2004-03-25
August, 2000 FDA 483 Response Sumitomo Chemical Company, Limited - Form 483R, 2000-12-21
April, 2004 EIR American Red Cross Blood Svcs - EIR, 2004-04-12
January, 2001 EIR Rex Hospital, Inc. - EIR, 2001-01-23
April, 2002 FDA 483 Alcami Carolinas Corporation - Form 483, 2002-04-08
August, 2000 EIR CIPLA LIMITED - EIR, 2000-08-24
January, 2000 EIR Merck Sharp & Dohme LLC - EIR, 2000-01-14
December, 2004 EIR Curia Italy S.r.l. - EIR, 2005-01-20
October, 2003 FDA 483 Bayer AG - Form 483, 2003-10-15
March, 2003 FDA 483 Response Purdue Pharmaceuticals L.P. - Form 483R, 2003-03-27
September, 2005 EIR Patheon Softgels Inc. - EIR, 2005-09-02
August, 2000 FDA 483 CIPLA LIMITED - Form 483, 2000-08-31
August, 2000 EIR Sumitomo Chemical Company, Limited - EIR, 2000-08-10
August, 2004 EIR Biogen MA Inc. - EIR, 2004-08-27
February, 2001 EIR Patheon Softgels Inc. - EIR, 2001-02-06
October, 2002 FDA 483 Response Abbott Laboratories - Form 483R, 2002-10-24
February, 2002 EIR Patheon Manufacturing Services LLC - EIR, 2002-02-08
February, 2004 EIR Kay Chemical Company - EIR, 2004-02-24
April, 2002 EIR Merck Sharp & Dohme LLC - EIR, 2002-04-22
December, 2004 FDA 483 Curia Italy S.r.l. - Form 483, 2004-12-13
October, 2002 EIR Abbott Laboratories - EIR, 2002-10-03
January, 2003 EIR Patheon Manufacturing Services LLC - EIR, 2003-01-22
June, 2001 EIR Jubilant HollisterStier General Partnership. - EIR, 2001-06-29
October, 2002 FDA 483 Abbott Laboratories, Inc. - Form 483, 2002-10-03
March, 2003 EIR Purdue Pharmaceuticals L.P. - EIR, 2003-03-13
December, 2000 EIR Patheon Manufacturing Services LLC - EIR, 2000-12-15
November, 2004 EIR Hospira, Inc. - EIR, 2004-11-12
August, 2004 EIR Biogen Idec, Inc. - EIR, 2004-11-05
January, 2000 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2000-01-14
April, 2000 FDA 483 Hospira, Inc. - Form 483, 2000-04-28
August, 2000 EIR CIPLA LIMITED - EIR, 2000-08-31
November, 2005 EIR PCAS - EIR, 2005-11-22
June, 2004 FDA 483 CMP Pharma, Inc. - Form 483, 2004-06-23
February, 2002 FDA 483 Response Patheon Manufacturing Services LLC - Form 483R, 2002-02-20
November, 2001 EIR PRZEDSIEBIORSTWO PRODUKCYJNO WDROZENIOWE IFOTAM SP Z O O ZAKLAD PRODUKCYJNY W LODZI - EIR, 2001-12-18
March, 2004 FDA 483 Grifols Therapeutics Inc. - Form 483, 2004-03-25
October, 2003 FDA 483 Response Bayer AG - Form 483R, 2004-01-27
December, 2000 FDA 483 Response Patheon Manufacturing Services LLC - Form 483R, 2001-01-03
February, 2002 FDA 483 Patheon Manufacturing Services LLC - Form 483, 2002-02-08
June, 2004 EIR CMP Pharma, Inc. - EIR, 2004-06-23
March, 2004 EIR AM2 PAT INC - EIR, 2004-03-01
December, 2003 EIR Purdue Pharmaceuticals L.P. - EIR, 2003-12-10
April, 2000 EIR Hospira, Inc. - EIR, 2001-01-25
January, 2002 EIR Eon Labs, Inc. - EIR, 2002-01-11
June, 2001 FDA 483 Response Jubilant HollisterStier General Partnership. - Form 483R, 2001-09-07
December, 2004 FDA 483 Response Curia Italy S.r.l. - Form 483R, 2005-02-17
July, 2002 EIR HonorBridge - EIR, 2002-07-24
February, 2004 FDA 483 Liebel-Flarsheim Company LLC - Form 483, 2004-02-05
July, 2004 FDA 483 Patheon Manufacturing Services LLC - Form 483, 2004-07-30
February, 2001 FDA 483 Patheon Softgels Inc. - Form 483, 2001-02-06
June, 2000 EIR The Procter & Gamble Manufacturing Company - EIR, 2000-06-13
December, 2003 FDA 483 Purdue Pharmaceuticals L.P. - Form 483, 2003-12-10
September, 2005 FDA 483 Patheon Softgels Inc. - Form 483, 2005-09-02
July, 2002 FDA 483 Leiner Health Products, Llc - Form 483, 2002-07-11
August, 2000 FDA 483 CIPLA PHARMACEUTICALS - Form 483, 2000-08-24
October, 2005 EIR Hospira, Inc. - EIR, 2005-10-11
October, 2003 FDA 483 Solvay Pharmaceuticals GmbH - Form 483, 2003-10-09
June, 2001 FDA 483 Jubilant HollisterStier General Partnership. - Form 483, 2001-06-29
November, 2001 FDA 483 PRZEDSIEBIORSTWO PRODUKCYJNO WDROZENIOWE IFOTAM SP Z O O ZAKLAD PRODUKCYJNY W LODZI - Form 483, 2001-11-07
July, 2003 EIR Alcami Carolinas Corporation - EIR, 2003-07-10
July, 2004 EIR Patheon Manufacturing Services LLC - EIR, 2004-07-30
February, 2000 EIR Bristol Myers Products Inc - EIR, 2000-02-11
November, 2001 FDA 483 Response PRZEDSIEBIORSTWO PRODUKCYJNO WDROZENIOWE IFOTAM SP Z O O ZAKLAD PRODUKCYJNY W LODZI - Form 483R, 2002-01-30
November, 2005 FDA 483 Response PCAS - Form 483R, 2005-11-22
July, 2004 EIR United Therapeutics Corporation - EIR, 2004-07-09
September, 2002 EIR SpecGx LLC - EIR, 2002-09-10

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more